Home › Hypertrophic Cardiomyopathy › Texas
Hypertrophic Cardiomyopathy clinical trials in Texas
3 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in Texas.
Cities in Texas
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- and 3 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Houston
- Imbria Investigational Site, Plano
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07023614Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
- Houston Methodist Hospital, Houston
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Mar 19, 2026 · NCT05836259From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.